Stage I Grade 1 Follicular Lymphoma Completed Phase 2 Trials for Rituximab (DB00073)

IndicationStatusPhase
DBCOND0029475 (Stage I Grade 1 Follicular Lymphoma)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01682044Pegfilgrastim and Rituximab in Treating Patients With Untreated, Relapsed, or Refractory Follicular Lymphoma, Small Lymphocytic Lymphoma, or Marginal Zone LymphomaTreatment
NCT00244855Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin LymphomaTreatment